|
1
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hamburger AW and Salmon SE: Primary
bioassay of human tumor stem cells. Science. 197:461–463. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Costea DE, Tsinkalovsky O, Vintermyr OK,
Johannessen AC and Mackenzie IC: Cancer stem cells - new and
potentially important targets for the therapy of oral squamous cell
carcinoma. Oral Dis. 12:443–454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
7
|
Seigel GM, Campbell LM, Narayan M and
Gonzalez-Fernandez F: Cancer stem cell characteristics in
retinoblastoma. Mol Vis. 11:729–737. 2005.PubMed/NCBI
|
|
8
|
Chumsri S, Phatak P, Edelman MJ, Khakpour
N, Hamburger AW and Burger AM: Cancer stem cells and individualized
therapy. Cancer Genomics Proteomics. 4:165–74. 2007.PubMed/NCBI
|
|
9
|
Locke M, Heywood M, Fawell S and Mackenzie
IC: Retention of intrinsic stem cell hierarchies in
carcinoma-derived cell lines. Cancer Res. 65:8944–8950. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tudor D, Locke M, Owen-Jones E and
Mackenzie IC: Intrinsic patterns of behavior of epithelial stem
cells. J Investig Dermatol Symp Proc. 9:208–214. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kiyosue T, Kawano S, Matsubara R, Goto Y,
Hirano M, Jinno T, Toyoshima T, Kitamura R, Oobu K and Nakamura S:
Immunohistochemical location of the p75 neurotrophin receptor
(p75NTR) in oral leukoplakia and oral squamous cell carcinoma. Int
J Clin Oncol. 18:154–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rabizadeh S and Bredesen DE: Ten years on:
Mediation of cell death by the common neurotrophin receptor
p75(NTR). Cytokine Growth Factor Rev. 14:225–239. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liepinsh E, Ilag LL, Otting G and Ibáñez
CF: NMR structure of the death domain of the p75 neurotrophin
receptor. EMBO J. 16:4999–5005. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rodríguez-Tébar A, Dechant G, Götz R and
Barde YA: Binding of neurotrophin-3 to its neuronal receptors and
interactions with nerve growth factor and brain-derived
neurotrophic factor. EMBO J. 11:917–922. 1992.PubMed/NCBI
|
|
16
|
Wang X, Bauer JH, Li Y, Shao ZH, Zetoune
FS, Cattaneo E and Vincenz C: Characterization of a p75(NTR)
apoptotic signaling pathway using a novel cellular model. J Biol
Chem. 276:33812–33820. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Harding TC, Xue L, Bienemann A, Haywood D,
Dickens M, Tolkovsky AM and Uney JB: Inhibition of JNK by
overexpression of the JNL binding domain of JIP-1 prevents
apoptosis in sympathetic neurons. J Biol Chem. 276:4531–4534. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park DS, Morris EJ, Bremner R, Keramaris
E, Padmanabhan J, Rosenbaum M, Shelanski ML, Geller HM and Greene
LA: Involvement of retinoblastoma family members and E2F/DP
complexes in the death of neurons evoked by DNA damage. J Neurosci.
20:3104–3114. 2000.PubMed/NCBI
|
|
19
|
Salehi AH, Xanthoudakis S and Barker PA:
NRAGE, a p75 neurotrophin receptor-interacting protein, induces
caspase activation and cell death through a JNK-dependent
mitochondrial pathway. J Biol Chem. 277:48043–48050. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krygier S and Djakiew D: Neurotrophin
receptor p75(NTR) suppresses growth and nerve growth
factor-mediated metastasis of human prostate cancer cells. Int J
Cancer. 98:1–7. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khwaja F and Djakiew D: Inhibition of
cell-cycle effectors of proliferation in bladder tumor epithelial
cells by the p75NTR tumor suppressor. Mol Carcinog. 36:153–160.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pflug BR, Onoda M, Lynch JH and Djakiew D:
Reduced expression of the low affinity nerve growth factor receptor
in benign and malignant human prostate tissue and loss of
expression in four human metastatic prostate tumor cell lines.
Cancer Res. 52:5403–5406. 1992.PubMed/NCBI
|
|
23
|
Okumura T, Shimada Y, Imamura M and
Yasumoto S: Neurotrophin receptor p75(NTR) characterizes human
esophageal keratinocyte stem cells in vitro. Oncogene.
22:4017–4026. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Campagnolo L, Russo MA, Puglianiello A,
Favale A and Siracusa G: Mesenchymal cell precursors of peritubular
smooth muscle cells of the mouse testis can be identified by the
presence of the p75 neurotrophin receptor. Biol Reprod. 64:464–472.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamamoto N, Akamatsu H, Hasegawa S, Yamada
T, Nakata S, Ohkuma M, Miyachi E, Marunouchi T and Matsunaga K:
Isolation of multipotent stem cells from mouse adipose tissue. J
Dermatol Sci. 48:43–52. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi H, Li DQ, Shine HD, Chen Z, Yoon KC,
Jones DB and Pflugfelder SC: Nerve growth factor and its receptor
TrkA serve as potential markers for human corneal epithelial
progenitor cells. Exp Eye Res. 86:34–40. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rota LM, Lazzarino DA, Ziegler AN, LeRoith
D and Wood TL: Determining mammosphere-forming potential:
Application of the limiting dilution analysis. J Mammary Gland Biol
Neoplasia. 17:119–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO,
Zheng BJ and Guan XY: Identification and characterization of
tumorigenic liver cancer stem/progenitor cells. Gastroenterology.
132:2542–2556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zen Y, Fujii T, Yoshikawa S, Takamura H,
Tani T, Ohta T and Nakanuma Y: Histological and culture studies
with respect to ABCG2 expression support the existence of a cancer
cell hierarchy in human hepatocellular carcinoma. Am J Pathol.
170:1750–1762. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Seo DC, Sung JM, Cho HJ, Yi H, Seo KH,
Choi IS, Kim DK, Kim JS, El-Aty AMA and Shin HC: Gene expression
profiling of cancer stem cell in human lung adenocarcinoma A549
cells. Mol Cancer. 6:752007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu SL, Dontu G, Mantle ID, Patel S, Ahn
NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1
regulate self-renewal of normal and malignant human mammary stem
cells. Cancer Res. 66:6063–6071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mitsutake N, Iwao A, Nagai K, Namba H,
Ohtsuru A, Saenko V and Yamashita S: Characterization of side
population in thyroid cancer cell lines: Cancer stem-like cells are
enriched partly but not exclusively. Endocrinology. 148:1797–1803.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu G, Yuan X, Zeng Z, Tunici P, Ng H,
Abdulkadir IR, Lu L, Irvin D, Black KL and Yu JS: Analysis of gene
expression and chemoresistance of CD133+ cancer stem cells in
glioblastoma. Mol Cancer. 5:672006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jin H, Pan Y, Zhao L, Zhai H, Li X, Sun L,
He L, Chen Y, Hong L, Du Y and Fan D: p75 neurotrophin receptor
suppresses the proliferation of human gastric cancer cells.
Neoplasia. 9:471–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dimaras H and Gallie BL: The p75 (NTR)
neurotrophin receptor is a tumor suppressor in human and murine
retinoblastoma development. Int J Cancer. 122:2023–2029. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Khwaja F, Tabassum A, Allen J and Djakiew
D: The p75(NTR) tumor suppressor induces cell cycle arrest
facilitating caspase mediated apoptosis in prostate tumor cells.
Biochem Biophys Res Commun. 341:1184–1192. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dang CX, Zhang Y, Ma QY and Shimahara Y:
Expression of nerve growth factor receptors is correlated with
progression and prognosis of human pancreatic cancer. J Gastroen
Hepatol. 21:850–858. 2006. View Article : Google Scholar
|
|
44
|
Marchetti D, Aucoin R, Blust J, Murry B
and Greiter-Wilke A: p75 neurotrophin receptor functions as a
survival receptor in brain-metastatic melanoma cells. J Cell
Biochem. 91:206–215. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Diamandis P, Wildenhain J, Clarke ID,
Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG,
Tyers M and Dirks PB: Chemical genetics reveals a complex
functional ground state of neural stem cells. Nat Chem Biol.
3:268–273. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Soland TM, Brusevold IJ, Koppang HS,
Schenck K and Bryne M: Nerve growth factor receptor (p75 NTR) and
pattern of invasion predict poor prognosis in oral squamous cell
carcinoma. Histopathology. 53:62–72. 2008. View Article : Google Scholar : PubMed/NCBI
|
